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Abstract.  Bone morphogenetic protein 2B (BMP 2B, 
also known as BMP 4) induces cartilage and bone 
morphogenesis in ectopic extraskeletal sites.  BMP 2B 
is one of several bone morphogenetic proteins which 
along with activins and inhibins are members of the 
transforming growth factor-/3  (TGF-B)  family.  Both 
BMP 2B and activin A, but not TGF-B~, induce rat 
pheochromocytoma PC12 neuronal cell differentiation 
and expression of VGF, a nervous system-specific 
mRNA.  PC12 cells exhibited •2,500  receptors per 
cell for BMP 2B with an apparent dissociation con- 
stant of 19 pM.  Extracellular matrix components, in- 
cluding fibronectin, laminin,  and collagen type IV 
potentiated the activity of BMP and activin A, with 
the latter being the most active.  Direct experiments 
demonstrated that radioiodinated BMP 2B bound to 
collagen type IV better than to either laminin or 
fibronectin.  These data demonstrate a common neuro- 
trophic activity of both BMP 2B and activin A, and 
suggest that these regulatory molecules alone and in 
conjunction with extracellular matrix components may 
play a role in both the development and repair of ner- 
vous tissue. 
ROWTH and  differentiation  factors  in  bone  enable 
demineralized  bone matrix  to induce endochondral 
bone formation  at ectopic sites  in rat  (Reddi  and 
Huggins,  1972).  Such bone-inducing  factors have been ex- 
tracted dissociatively from demineralized  bone matrix by 
chaotropic reagents  and reconstituted to demonstrate bio- 
logical  activity (Sampath  and Reddi,  1981). Six  different 
bone morphogenetic  factors  (BMP 2-7) 1 have been iden- 
tiffed (Wozney et al., 1988; Luyten et al., 1989). The BMPs 
are members of a family of growth and differentiation poly- 
peptides that includes activins A and B, inhibins, transform- 
ing  growth  factor-/3  (TGF-/3), the  Drosophila  decapenta- 
plegic gene complex,  Mullerian  inhibiting  substance (for 
review see Massague, 1990), and growth and differentiation 
factor-1 (Lee,  1990).  The different members of this super- 
family have been implicated  in various aspects of embryonic 
development. For example, Osteogenin/BMP 3, BMP 2, BMP 
2B (also known as BMP 4), and osteogenic protein (BMP 7) 
induce endochondral  bone induction in ectopic sites (Luyten 
et al., 1989; Ozkaynak et al., 1990; Hammonds et al., 1991; 
Wozney et al.,  1988).  Osteogenin/BMP 3 stimulates  both 
alkaline  phosphatase activity and collagen  synthesis  in rat 
periosteal cells and in calvarial osteoblasts (Vukicevic et al., 
1989).  Activins have been shown to stimulate  secretion of 
follicle stimulating  hormone and are important in neuronal 
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survival (Vale et al., 1986; Schubert and Kimura, 1991). Ac- 
tivins have also been implicated  in mesoderm induction  in 
amphibians  (Thomsen et al.,  1990). 
The activity of growth and differentiation  factors can be 
modulated by components of the extraceUular matrix (Paralkar 
et al., 1990; Ruoslahti and Yamaguchi, 1991). For example, 
heparin  and heparan sulfate modulate the activity of fibro- 
blast growth factors (Yayon et al., 1991). Many other growth 
and differentiation factors, which include neurite-promoting 
factor,  pleiotropin,  and  granulocyte-macrophage  colony- 
stimulating  factor,  have been shown  to bind heparin  and 
heparan sulfate present in the extracellular  matrix molecules 
(Ruoslahti and Yamaguchi, 1991). Extracellular matrix mac- 
romolecules are also known to contain growth factor-like se- 
quences and  can induce the differentiation  of various cell 
types. For example,  laminin and entactin contain EGF-like 
domains, and laminin can induce neuronal cell lines and pri- 
mary neurons to extend processes (Baron van Evercooren et 
al.,  1982;  Engel,  1989;  Durkin  et al.,  1988;  Reh et al., 
1987).  Another basement membrane component, collagen 
type IV, affects the attachment,  spreading,  and migration  of 
various cell types (Herbst et al., 1988; Aumailley and Timpl, 
1986).  Recent work has  also strongly  implicated  collagen 
type IV in neurite outgrowth (Lein et al., 1991; Mirre et al., 
1992). Osteogenin/BMP 3 and TGF-/3 bind to collagen type 
IV which is present in basement membrane (Paralkar  et al., 
1990, 1991b). 
We report here that BMP 2B has neurotrophic  activity and 
induces the differentiation of rat pheochromocytoma (PC12) 
cells.  The neurotrophic  effects of BMP 2B are shared  to a 
lesser extent by activin A but not by TGF-fl~. We also show 
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ity of BMP 2B with type IV collagen being the most active. 
Materials and Methods 
Materials 
Recombinant human BP 2B (rBMP 2B), TGF-/~I, and activin A were gifts 
of Dr. Glenn Hammonds (Genentech Inc., San Francisco, CA). Basic FGF, 
and the AA, BB, AB isoforms of PDGF were kindly provided by Dr. Glenn 
Pierce (Amgen Biologicals, Thousand Oaks,  CA).  Nerve growth factor 
(NGF) was purchased from Sigma Chem. Co., St. Louis, MO. The plasmid 
containing the VGF probe was a gift of Dr. Bruce Patterson (National Can- 
cer Institute). Collagen type IV and laminin were prepared from the murine 
EHS  tumor  as  previously  described (Kleinman et  al.,  1982).  Human 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)  cDNA  was  from 
American Type Culture Collection, Rockville, MD (No. 57090). 
Cell Culture and Neurite Outgrowth Assay 
The PC12 cells (a gift of Dr. G. Guroff, National Institute of Child Health 
and Human Development) were grown in DME containing 7.5%  FCS and 
7.5% horse serum. For initial assessment, PC12 cells were cultured in 100- 
mm tissue culture plates in DME containing serum. Various growth factors 
such as NGF, FGE PDGF isoforms An,, AB, and BB, BMP 2B, activin A, 
and TGF-/~ were then added at a final concentration of 0.1-50 ng/ml. After 
48 h, the ceils were photographed using ASA400 film. 
For neurite outgrowth assays, PC12  cells were washed extensively in 
serum-free DME/Ham's 1=12 (1:1) containing 100 #g/ml transferrin, 100 #m 
putrescine, 20 nM progesterone, 30 mM NaSeO3,  and 5  #g/ml insulin. 
Cells (10,000/0.5 rnl) were then plated in a 24-well tissue culture plate where 
the wells had been either untreated or coated with either 10 #g laminin, 
poly-L-lysine, fibronectin, or collagen type IV in PBS for 1 h at 37~  NGE 
activin A, or BMP 2B were added at the indicated concentrations (see figure 
legends) and process formation was quantitated after 24 h. Cells were con- 
sidered positive for formation if the process length equaled or was greater 
than one cell diameter. A total of 100 ceils were scored per data point. For 
photomicrographs, the cells were fixed and stained with Diff Quick (Ameri- 
can Scientific Products Division, McGaw Park,  IL).  In separate experi- 
ments, the effect of a bacterial alkaloid K-252a on the ability of both activin 
A and BMP 2B to stimulate PC12 cell neurite outgrowth was tested. PC12 
cells were cultured on 16-mm-diam wells which had been coated with 0.1 
#g/well of type IV collagen. Different growth factors (50 ng/ml) were added 
along with K-252a at the time of cell seeding and then the cells were fixed 
after 24 h  of incubation.  The stock solution of K-252a was prepared in 
100% DMSO and diluted in DME for use. DMSO alone at the concentra- 
tion used had no effect on PC12  cells. 
For cell attachment, collagen type IV, laminin, polylysine, and flbronec- 
tin were coated as described for neurite outgrowth assays, but after coating, 
each well was incubated at 37*C for I h with a solution of 3% BSA. Cells 
(50,000/well) were plated in the presence or absence of BMP 2B (50 ng/ml). 
After 1 h, unattached cells were removed by aspiration and attached cells 
were fixed and stained with Diff Quick. The number of cells was counted 
in three fields at 10x  and the mean +  standard error is presented. 
Iodination of BMP 2B and Binding Assay 
PC12 cells were examined for their ability to bind radioactive BMP 2B in 
a specific and saturable manner. Recombinant BMP 2B was iodinated by 
the chloramine T method as described previously (Paralkar et al., 1991a). 
For Scatchard analysis, PC12 ceils were washed three times with DME con- 
taining 1 mg/ml BSA and 20 mM Hepes (binding medium). The ceils were 
then incubated in binding medium. After 1 h, the cells were centrifuged and 
resuspended at a final density of 3  x  106/ml in binding medium.  100 t~l 
of the cell suspension was then mixed with 100/~1 of binding medium con- 
taining increasing concentrations of II25-1abeled BMP 2B in a siliconized 
microfuge tube. After incubation with radiolabeled BMP 2B for 1 h at room 
temperature, 1 ml of ice cold binding buffer was added to each tube and 
the tubes were centrifuged at 12,000 g for 2 min. 600 #1 of buffer from each 
tube was then removed and the radioactivity was determined in a gamma 
counter (Beckman Instrs., Inc., Fullerton, CA). The remaining medium 
was then removed and the cell pellet was resuspended in 100 #1 of binding 
buffer.  The resuspended cell pellet was then layered on top of a 200-/~1 oil 
parafin mixture in a 400-#1 microfuge tube. The tubes were then centrifuged 
at 12,000  g for 2 min. At the end of centrifugation, the supernate was re- 
moved and the bottom of the tube containing the cell pellet was cut with 
a razor blade and the radioactivity was determined in a gamma counter. 
Each time point was determined in triplicate. Nonspecific binding was de- 
termined by using a  100-fold  excess of unlabeled BMP 2B. 
The  binding  of iodinated  BMP  2B  to  extracellnlar  matrix  macro- 
molecules was determined as previously described (Paralkar et al., 1990). 
Briefly, the various macromolecules were applied to a nitrocellulose mem- 
brane in a final volume of 100 #1. The membrane was first blocked by incu- 
bation with 3% BSA in PBS containing 0.05% Tween 20 (TPBS), and then 
incubated with radioactive BMP 2B in TPBS. After incubation with BMP 
2B, the membrane was washed and then exposed to x-ray film for autoradi- 
ography. 
Detection of VGF Synthesis 
100-mm tissue culture plates were coated either with collagen type I or col- 
lagen type IV. PC12 cells extensively washed with serum-free DME were 
then seeded (5 x  106 per plate) in serum-free DME and treated with either 
NGF, activin A, or BMP 2B (50 ng/ml) for 5 h. Control cells did not receive 
any growth factor. After incubation, total RNA was prepared from the cells 
as described (Chomczynski and Saachi, 1987).  Approximately 10 #g of to- 
tal RNA from each treatment was subjected to electrophoresis on agarose- 
formaldehyde gels and transferred to Nytran membranes (Schleicher & 
Schuell, Inc., Keene, NH). The blot was hybridized with 32p-labeled VGF 
fragment  (EcoI,  HindIII)  and  32p-labeled  human  GAPDH  probe.  The 
amount of induction of VGE  a  nervous system-specific transcript, was 
quantified by scanning the autoradiographs with a densitometer using the 
amount of GAPDH hybridized for normalization. 
Results 
Neurite Outgrowth in Response to BMP 2B and to 
Activin A 
We studied the effect of BMP 2B and activin A on rat pheo- 
chromocytoma PC12 cells. BMP 2B and activin A  stimu- 
lated neurite outgrowth in PC12 cells (Fig. 1). The specificity 
and magnitude of the response of PC12 cells were tested 
using  several  other polypeptide growth  factors  including 
members of the TGF-/~ superfamily such as activin A and 
TGF-~.  Table  I  shows  that  of the  factors  tested,  NGF 
(positive control), basic FGF, BMP 2B, and activin A had 
neurotrophic activity for PC12 cells whereas TGF-/~ or the 
various isoforms of platelet-derived growth factor (AA, AB, 
and BB) had no neurotrophic activity. Activin has been pre- 
viously  shown  to  be  a  neuronal  cell  survival  molecule 
(Schubert et al.,  1990). Activin A  can also induce neurite 
outgrowth in PC12 cells but was not as active as BMP 2B or 
NGF. In these experiments, the different growth factors were 
tested in the presence of serum. We next determined if the 
effect of both BMP 2B and activin A  was demonstrable in 
the absence of serum components. Both BMP 2B and activin 
A were ineffective in the absence of serum (data not shown). 
Effect of Extracellular Matrix Macromolecules 
Since many growth factors act in combination with extracel- 
lular matrix components, the effects of extracellular matrix 
macromolecules on the neurotrophic activity of both BMP 
2B and activin A were tested. When the matrix components 
were  present  at  a  substratum,  activity  was  observed  in 
serum-free conditions. NGF has been shown to be a potent 
stimulator of neurite outgrowth especially  in combination 
with laminin and was used as a positive control. Like NGF, 
BMP  2B  and  activin  A  had  higher  neurotrophic  activity 
when the cells were plated on either fibronectin, laminin, or 
The Journal  of Cell Biology,  Volume  119, 1992  1722 Figure L  Induction of neurite outgrowth in PC12 cells treated  with various growth factors.  PCI2 cells were cultured in 100-mm tissue 
culture dishes in the presence of medium containing  serum. Different growth factors at 50 ng/ml were then added and the cells were fixed 
after 48 h. (a) Control PC12 cells,  (b) PC12 cells with TGF-/~, (c) PC12 cells with activin A, (d) PC12 cells with NGF, and (e) PC12 
cells with BMP 2B. 
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PC12 Cells in the Presence of  Serum  Extracellular Matrix Macromolecules 
Growth factor  Neurite extension 
NGF  + + + 
Basic FGF  + 
BMP2B  +  + 
Activin A  + 
TGF-#: 
PDGF AA 
PDGF BB 
PDGF AB 
IGF-1 
+ + +  corresponds to 70-100% of the cells; + +  corresponds to 40-70% 
of  the cells; and + corresponds  to 40% of  the cells having  significant  process- 
es. -  signifies  lack of neurite extension. Cells were treated with the indicated 
growth factors for 48 h in the presence of serum. Neurite process forma- 
tion was enumerated when the process length was greater than one cell di- 
ameter. The experiment was repeated two times and each factor  was tested in 
triplicates. 
collagen type IV than when tested on poly-L-lysine-coated 
plastic or on plastic alone (Fig.  2).  Poly-L-lysine is highly 
adhesive for the cells used and was used as a control to ex- 
clude adhesion effects from the differentiation activity. Poly- 
L-lysine did not stimulate neurite outgrowth in the presence 
or absence of growth factors but was as active as laminin and 
collagen type IV for cell attachment.  Iauninin and collagen 
Figure 2. Effect of BMP 2B and activin A on neurite outgrowth in 
the presence of extraceUular matrix components. PC12 cells were 
cultured  in duplicate  16-mm-diam wells  which had been coated 
with 10 #m collagen type IV, laminin,  fibronectin,  or poly-L-lysine. 
Cells were grown in uncoated plates and primed for 24 h with 50 
ng/ml of BMP 2B, activin A, or NGF. After 24 h, cells were har- 
vested,  washed  free  of  serum,  and  then  transferred  to  plates 
precoated with extracellular  matrix macromolecules. Growth fac- 
tors (50 ng/ml) were added and the cells were cultured  for an addi- 
tional 24 h in the absence of serum. At the end of incubation,  100 
cells were counted in two fields/well for neurite outgrowth activity. 
Cells with processes greater than one cell diameter were considered 
positive.  The number of positive  cells was enumerated and pre- 
sented  as the mean •  SEM. 
Cells/fieid* 
Substratum  No addition  BMP  2B 
Fibronectin  44 +  6  54  +  4 
Laminin  104 +  4  116 •  14 
Collagen type IV  130 •  4  139 •  8 
Poly-L-lysine  124 +  10  118 •  6 
Control plastic  10 •  2  6  •  2 
Cells were plated on plastic wells coated  with various  extracellular molecules 
in the presence (50 ng/ml) or absence of BMP 2B. 
* The results are mean + SE of three different fields. 
type IV t0/~g/well) were approximately equally active and 
more active than fibronectin in potentiating the effect of  both 
BMP 2B and acflvin A. These differences could not be attrib- 
uted to attachment alone since attachment to laminin, colla- 
gen type IV,  and poly-L-lysine was  identical  and  was not 
affected by  BMP  2B  treatment  (Table  II).  Attachment  to 
fibronectin was less than to laminin,  collagen type IV, and 
poly-L-lysine, which may explain in part the reduced activity 
of fibronectin. When varying doses of collagen type IV and 
lamim'n were used, BMP 2B was more active at lower doses 
of collagen type IV  (0.001-1  #g/well)  when compared to 
laminin at the same levets 0~ig. 3). At higher amounts, both 
lamim'n and collagen type IV were equally active in poten- 
flaring the effects of BMP 2B. 
Since BMP 2B and activin A promoted PC12 cell differen- 
tiation,  the mechanism of action was investigated.  K-252a, 
a bacterial alkaloid,  is an inhibitor of NGF-induced neurite 
extension in PC12 cells but does not affect FGF-induced neu- 
rite extension (Koizumi et al.,  1988; Weeks et al.,  1990). 
K-252a inhibited the effects of  NGF, aetivin A, and BMP 2B 
by 84, 42, and 95 %, respectively, on a collagen IV substra- 
tum.  Thus,  both BMP 2B and acrivin A  likely stimulate  a 
second messenger pathway common to that elicited by NGF. 
Binding of  Radiolabeled BMP 2B to ExtraceUular 
Matrix Macromolecules 
Since collagen type IV potentiated the activity of BMP 2B 
better than laminin, and osteogenin/BMP 3 is known to bind 
collagen type IV (Paralkar  et al.,  1990),  collagen type IV 
binding to iodinated BMP 2B was tested. Iodinated BMP 2B 
bound to collagen type IV preferentially over laminin (Fig. 
3 B). No binding was observed for other collagens tested in- 
cluding collagen II, IX, and XI; and relatively weak binding 
was observed to collagen I. Matrigel which is composed of 
laminin (70%) and collagen IV (5 %) also had some binding. 
Thus, BMP 213 appears to specifically interact with collagen 
IV over other matrix proteins. 
Dose Response of  BMP 2B, Activin A and NGF 
The effect of BMP 2B, acflvin A, and NGF on collagen type 
IV  was  concentration  dependent  (Fig.  4).  BMP  2B  had 
~50 % of the activity of NGE The concentration of all three 
factors  at  half-maximal  response  is  very  similar  (0.3-0.6 
nM) but it should be noted that the maximal responses pla- 
teau at different levels. The difference between the effect of 
NGF and BMP 2B increases as the concentration increases 
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Figure  3. (A) Neurite outgrowth promoting activity ofBMP 2B with 
cells cultured on various amounts of collagen type IV and laminin. 
BMP 2B was added at 50 ng/ml at the time of PC12 cell seeding into 
16-mm-diam  wells  which  had  been  coated  with  the  indicated 
amounts of  either collagen type IV or laminin.  Duplicate wells were 
prepared and 100 cells/well were counted in the center field of each 
well.  The number of cells with processes lx the cell diameter or 
greater is presented as the mean +  SD. (B) Collagen types I, II, 
IV, IX, and XI, laminin,  Matrigel,  and BSA were immobilized on 
nitrocellulose  at three different concentrations (0.1, 1, and 10/xg). 
The nitrocellulose  membrane was then incubated  with radioactive 
BMP 2B, washed,  and exposed to x-ray film for autoradiography. 
(above  1 riM).  Maximum response  to BMP 2B is  ,,ol  nM 
whereas the maximum response to NGF is seen at ,,o2.5 nM. 
Demonstration of  Specific usI-BMP 2B Binding to 
PC12 Cells 
Radiolabeled  BMP  2B  bound  in  a  specific  and  saturable 
nM 
Figure 4. Effect of  equimolar doses of  NGF, BMP 2B, and activin A 
on neurite  outgrowth.  PC12 cells were cultured on 16-mm-diam 
wells which had been coated with 0.1 t~g/well of collagen type IV. 
The growth factors were added at the time of cell seeding and then 
the cells were fixed after 24 h of incubation.  100 cells were counted 
in the center field of  each well at lOx and cells with process length 
lx  the cell diameter were considered positive. 
manner to rat pheochromocytoma cells with a  dissociation 
constant of 19 pM with 2,500 receptors per cell (Fig. 5). A 
low  number  of high  affinity  sites  has  been  demonstrated 
for BMP  2B  in  other  cell  types  (Paralkar  et  al.,  1991a). 
PC12 cells bound radiolabeled NGF in a specific and satura- 
ble  manner  (data  not  shown).  NGF  did  not compete  for 
BMP 2B. 
Regulation of VGF mRNA Levels in PC12 Cells 
We  examined  the  induction  of a  nervous  system-specific 
VGF mRNA expression to verify the state of differentiation 
of PC12 cells. Cells were grown on plates coated with either 
collagen type I  or collagen type IV.  Northern  analysis  of 
transcripts  showed a  rapid induction of VGF mRNA when 
cells were treated with either NGF, BMP 2B,  or activin A 
(Fig. 6). The induction was maximum for NGF (seven- and 
fourfold over control for cells grown on collagen types I and 
IV, respectively) but was also significant for both activin A 
(five- and threefold) and BMP 2B (seven- and threefold over 
control). 
Discussion 
This report establishes that BMP 2B, a bone morphogenetic 
protein,  stimulates  neurite extension in rat pheochromocy- 
toma PC12 cells via functional receptors for BMP 2B. These 
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Figure 5.  Binding of 1251 BMP 2B to PC12 cells. 
PCI2 cells were incubated with increasing concen- 
trations of BMP 2B at room temperature for 1 h. 
Specifically bound  radioactivity  was determined 
by subtracting nonspecific binding from total cell- 
bound  radioactivity  for each data point.  (Inset) 
Scatchard analysis of the binding data.  B, bound; 
F, free. 
effects ofBMP 2B on PC12 cells are similar to those demon- 
strated for NGF and were also exhibited by activin A. In ad- 
dition,  activin  has  been  demonstrated  to  be  involved  in 
mesoderm induction in Xenopus (Thomsen et al.,  1990). In 
serum-free conditions in vitro, the effect of all three factors 
is dependent on the extracellular matrix component used to 
coat the tissue culture wells. Collagen type IV was the most 
potent extracellular matrix macromolecule tested. The dif- 
ferences in activity of the matrix molecules used to coat the 
wells cannot be explained on the basis of differences in cell 
attachment, since poly-L-lysine which is as potent as colla- 
gen type IV in promoting cell attachment does not stimulate 
neurite outgrowth in the presence or absence ofBMP 2B. We 
have previously shown that purified bovine osteogenin/BMP 3 
and TGF-/~ and TGF-/~2 bind to collagen type IV, and that 
collagen type IV can modulate the activity of TGF-fl (Paralkar 
et al.,  1990;  Paralkar et al.,  1991b).  Radiolabeled recom- 
binant human BMP 2B also has an affinity for collagen type 
IV preferentially over that observed for laminin. The obser- 
vation that collagen type IV had a similar ability to promote 
the  activity of all  three growth and  differentiation factors 
suggests a possible common pathway for the action of BMP 
Figure 6.  Induction  of VGF 
mRNA synthesis by BMP 2B, 
NGF, and activin A. Northern 
blot analysis of mRNA from 
PCI2 ceils grown on collagen 
type I (lanes a, c, e, and g) or 
IV (lanes b, d, f, and h) and 
treated  with  NGF,  BMP  2B, 
or  activin  A.  Control  wells 
were  not  treated  with  any 
growth  factor.  RNA  (15  #g) 
was separated  in  1%  agarose 
gel containing  formaldehyde, 
and  immobilized  on Nytran. 
The  autoradiograph  shows 
results of hybridizations with 
VGF  and  GAPDH  probes. 
Lanes a  and b are control,  c 
and d were treated with NGF, 
e and f  with BMP 2B, and g 
and h with activin A. The au- 
toradiograph  was scanned by 
densitometry. 
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the ability of both activin A and BMP 2B to stimulate gene 
expression of VGF and the ability of K-252a to inhibit the 
activity of both BMP 2B and activin A. The precise mecha- 
nism of action of all three factors is unknown. The activin 
receptor is a membrane-spanning serine/threonine protein 
kinase (Mathews and Vale, 1991) whereas the NGF receptor 
is a protein tyrosine kinase (Kaplan et al.,  1991). 
Much is known about the role of extracellular matrix mac- 
romolecules in tissue repair, cell attachment, and differentia- 
tion  (Reddi,  1984;  Engel,  1989; Kleinman et al.,  1990). 
Numerous  other  functions  have been  ascribed  to the ex- 
traceUular matrix macromolecules.  Laminin,  for example, 
has been shown to be able to differentiate epithelial cells in 
vitro (Reh et al.,  1987).  Attention has been focused on ex- 
tracellular matrix macromolecules  because of their ability 
to bind growth and differentiation factors (Folkman et at., 
1988; Paralkar et al., 1990;  1991b; Ruoslahti and Yamagu- 
chi, 1991). The extracellular matrix macromolecules might 
play an important physiological  role in  sequestration and 
modulation of activity of growth and differentiation factors. 
These interactions of growth and differentiation factors with 
extracellular matrix macromolecules may result in the local- 
ization of a bioactive molecule at the appropriate site in vivo 
to facilitate local action by preventing diffusion of soluble 
growth factors. There are numerous advantages in the inter- 
action of extracellular matrix macromolecules  with growth 
and differentiation factors, such as protection from proteo- 
lytic degradation, availability of high concentration of active 
molecules at the appropriate site, and minimizing the rate of 
diffusion. This investigation demonstrates that collagen type 
IV not only binds BMP 2B but also modulates the activity 
of BMP 2B on PC12 cells. 
The in vivo role of different BMPs for functions other than 
bone induction has not yet been demonstrated. The expres- 
sion pattern ofBMP 2A mRNA in various tissues, including 
brain, by in situ hybridization lends further support to the 
physiological significance of the present study (Lyons et al., 
1990).  There are now six different BMPs (BMP 2 through 
7) present in bone which can induce bone at ectopic sites in 
the in vivo bioassay. Although these BMPs were isolated by 
in vivo bone morphogenetic bioassay, it is possible that some 
of these BMPs might be involved in embryonic development 
and repair of other tissues.  Indeed this possibility  is sup- 
ported by the present results demonstrating the neurotrophic 
activity ofBMP 2B. In conclusion,  recombinant human bone 
morphogenetic protein 2B is a neurotrophic molecule and its 
activity is increased by collagen  type IV. 
Received for publication 22 January 1992 and in revised form 8 September 
1992. 
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